READ Act

Work to establish Federal limits on pre-dispute arbitration agreements. Work in support of amendments to the Federal Arbitration Act, including enactment of S.2506 and similar bills that would reduce or eliminate the use of predispute arbitration agreements. Work in opposition to H.R.526 and S.357, the Further Asbestos Claims Transparency Act of 2015. Work in support of S.700, the Reducing Exposure to Asbestos Data Base Act of 2015. Work in opposition to H.R.758 and S.401, the Lawsuit Abuse Reduction Act of 2015; H.R. 1927, the Fairness in Class Action and Furthering Asbestos Claim Transparency Act of 2015; and H.R.3624, the Fradulent Joinder Prevention Act of 2016.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; H.R. 4923, American Manufacturing Competitiveness Act of 2016; H.R. 5538, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; S. 2794, American Manufacturing Competitiveness Act of 2016; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Building and Construction water infrastructure; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Labeling, including GMOs; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Titanium Dioxide; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

Tort issues including asbestos bankruptcy trusts H.R.526 - Furthering Asbestos Claim Transparency (FACT) Act of 2015 S.357 - FACT Act H.R. 9- the Innovation Act (patent) S. 1137- Patent Act S. 632- STRONG Patents Act of 2015 H.R. 758- Lawsuit Abuse Reduction Act (LARA) H.R. 1927- Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016 S. 700 READ Act H.R. 5618 Enhancing United States Trustee Oversight Act of 2016

Client expense: $480,000 · Firm income: Not reported

Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT), Treasury, Dept of

Work to establish Federal limits on pre-dispute arbitration agreements. Work in support of amendments to the Federal Arbitration Act, including enactment of S.2506 and similar bills that would reduce or eliminate the use of predispute arbitration agreements. Work in opposition to H.R.526 and S.357, the Further Asbestos Claims Transparency Act of 2015. Work in support of S.700, the Reducing Exposure to Asbestos Data Base Act of 2015. Work in opposition to H.R.758 and S.401, the Lawsuit Abuse Reduction Act of 2015; H.R. 1927, the Fairness in Class Action and Furthering Asbestos Claim Transparency Act of 2015; and H.R.3624, the Fradulent Joinder Prevention Act of 2016.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; H.R. 4923, American Manufacturing Competitiveness Act of 2016; H.R. 5538, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; S. 2794, American Manufacturing Competitiveness Act of 2016; S. 3068, Department of the Interior, Environment, and Related Agencies Appropriations Act of 2017; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Building and Construction water infrastructure; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Tort issues including asbestos bankruptcy trusts H.R.526 - Furthering Asbestos Claim Transparency (FACT) Act of 2015 S.357 - FACT Act H.R. 9- the Innovation Act (patent) S. 1137- Patent Act S. 632- STRONG Patents Act of 2015 H.R. 758- Lawsuit Abuse Reduction Act (LARA) H.R. 1927- Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016 S. 700 READ Act

Client expense: $340,000 · Firm income: Not reported

Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

Work to establish Federal limits on pre-dispute arbitration agreements. Work in support of amendments to the Federal Arbitration Act, including enactment of S.2506 and similar bills that would reduce or eliminate the use of predispute arbitration agreements. Work in opposition to H.R.526 and S.357, the Further Asbestos Claims Transparency Act of 2015. Work in support of S.700, the Reducing Exposure to Asbestos Data Base Act of 2015. Work in opposition to H.R.758 and S.401, the Lawsuit Abuse Reduction Act of 2015; H.R. 1927, the Fairness in Class Action and Furthering Asbestos Claim Transparency Act of 2015; and H.R.3624, the Fradulent Joinder Prevention Act of 2016.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; FY 2017 Appropriations of Commerce, Justice, Science and Related Agencies; FY 2017 Appropriations of Department of Interior; FY 2017 Appropriations of Financial Services and General Government; FY 2017 Appropriations of Department of Labor, Health and Human Services; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Crystalline Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

Tort issues including asbestos bankruptcy trusts H.R. 526 - Furthering Asbestos Claim Transparency (FACT) Act of 2015 S. 357 - FACT Act H.R. 9- the Innovation Act (patent) S. 1137- Patent Act S. 632- STRONG Patents Act of 2015 H.R. 758- Lawsuit Abuse Reduction Act (LARA) H.R. 1927- Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2016 S. 700 READ Act

Client expense: $360,000 · Firm income: Not reported

Government targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections; S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections; H.R.2576 - TSCA Modernization Act of 2015, all sections; and H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections.

Client expense: $7,452 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections; S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections; H.R.2576 - TSCA Modernization Act of 2015, all sections; and H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections.

Client expense: $211,173 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Work to establish Federal limits on pre-dispute arbitration agreements. Work in support of amendments to the Federal Arbitration Act, including enactment of S.2506 and similar bills that would reduce or eliminate the use of predispute arbitration agreements. Work in opposition to H.R.526 and S.357, the Further Asbestos Claims Transparency Act of 2015. Work in support of S.700, the Reducing Exposure to Asbestos Data Base Act of 2015. Work in opposition to H.R.758 and S.401, the Lawsuit Abuse Reduction Act of 2015; H.R. 1927, the Fairness in Class Action and Furthering Asbestos Claim Transparency Act of 2015; and H.R.3624, the Fradulent Joinder Prevention Act of 2016.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 01-19-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 01-19-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. General lobbying with regard to consumer use and safety of unmanned aerial systems. H.R. 3669 (SAFE DRONE Act of 2015); amends title 18, United States Code, to provide a criminal penalty for operating drones in certain locations. General lobbying on aviation safety. H.R. 1062/S. 571 (Pilot's Bill of Rights 2); amends the Pilot's Bill of Rights to facilitate appeals and to apply to other certificates issued by the Federal Aviation Administration, to require the revision of the third class medical certification regulations issued by the Federal Aviation Administration.

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; H.R. 3977, Trash Reduction Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Alternative Fuel Tax Assessment; Bisphenol A; Chemical Assessment; Chemical Safety Board; Chemistry Caucus (Creation and Recruitment); Chlorinated Paraffins; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Fluorotechnology; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); OSHA Silica Rule; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $20,518 · Firm income: Not reported

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $110,419 · Firm income: Not reported

Work to establish Federal limits on pre-dispute arbitration agreements. Work in opposition to H.R. 526 and S. 357, the Further Asbestos Claims Transparency Act of 2015. Work in support of S.700, the Reducing Exposure to Asbestos Data Base Act of 2015.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-19-2015; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-19-2015; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. S. 1900/H.R. 3830 (Bipartisan Congressional Trade Priorities Act); establishes Congressional trade negotiating objectives and enhanced consultation requirements for trade negotiations, provides for consideration of trade agreements, and for other purposes. S. 2171 (Location Privacy Protection Act); specific interest in limitations on liability and preemption of state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 4921; provides for the revision of certification requirements for the labeling of certain electronic products under the Energy Star program. S. 2615; establishes criminal penalties for failing to inform and warn of serious dangers. H.R. 4 (Jobs for America Act); revises Federal law to improve the conditions necessary for economic growth and job creation. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 3020/S. 1695 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016); making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2016. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. General lobbying with regard to consumer use and safety of unmanned aerial systems. H.R. 3669 (SAFE DRONE Act of 2015); amends title 18, United States Code, to provide a criminal penalty for operating drones in certain locations. General lobbying on aviation safety.

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $44,850 · Firm income: Not reported

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and S. ____ - Legislation that would increase transparency about the location of asbestos in consumer products and elsewhere in commerce.

Client expense: $184,647 · Firm income: Not reported

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations of Environmental Protection Agency; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Bisphenol A; Chemical Safety Board; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Formaldehyde; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; OSHA Letters of Interpretation (Chemical Concentrations, Process Safety, RAGAGEP); Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Risk Assessment Improvements; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Work to establish Federal limits on pre-dispute arbitration agreements. Work in opposition to H.R. 526 and S. 357, the Further Asbestos Claims Transparency Act of 2015. Work in support of S.700, the Reducing Exposure to Asbestos Data Base Act of 2015.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 527; Small Business Regulatory Flexibility Improvements Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; H.R. 2576; TSCA Modernization Act of 2015; H.R. 2577, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2016; H.R. 2822, Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016; H.R. 2995, Financial Services and General Government Appropriations Act, 2016; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; S. 1014, Personal Care Products Safety Act; S. 1447, Sustainable Chemistry Research and Development Act of 2015; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Bisphenol A; Chemical Safety Board; CPSC; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Formaldehyde; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Good Science; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Microplastics; Nanotechnology; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Report on Carcinogens; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database (READ) Act of 2015, all sections; and H.R.526 and S.357 - Furthering Asbestos Claim Transparency (FACT) Act, all sections.

Client expense: $51,797 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R.2576 - TSCA Modernization Act of 2015, all sections; H.R.2030 and S.700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; H.R.526 and S.357 - Furthering Asbestos Claim Transparency (FACT) Act, all sections; and S. ___ - Legislation to address health risks posed by flame retardant chemicals.

Client expense: $180,613 · Firm income: Not reported

H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-17-2015; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-17-2015; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. S. 1999/H.R. 4068 (SCRA Rights Protection Act of 2014); amends the Servicemembers Civil Relief Act to require the consent of parties to contracts for the use of arbitration to resolve controversies arising under the contracts and subject to provisions of such Act and to preserve the rights of servicemembers to bring class actions under such Act, and for other purposes. H.R. 1910 (Foreign Manufacturers Legal Accountability Act); requires foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. S. 1900/H.R. 3830 (Bipartisan Congressional Trade Priorities Act); establishes Congressional trade negotiating objectives and enhanced consultation requirements for trade negotiations, provides for consideration of trade agreements, and for other purposes. S. 2171 (Location Privacy Protection Act); specific interest in limitations on liability and preemption of state-based causes of action. S. 2393 (Servicemember Employment Protection Act); makes unenforceable any clause of an agreement between an employer and employee requiring arbitration of a dispute arising under the Uniformed Services Employment and Reemployment Rights Act (USERRA). Provides an exception when both parties voluntarily agree to arbitration. Requires any issue as to whether such requirement applies to an arbitration clause to be determined by federal law and the validity or enforceability of an agreement to arbitration to be determined by a court rather than an arbitrator. H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 4921; provides for the revision of certification requirements for the labeling of certain electronic products under the Energy Star program. S. 544/H.R. 1040 (Secret Science Reform Act of 2015); prohibits the Environmental Protection Agency from proposing, finalizing, or disseminating regulations or assessments based upon science that is not transparent or reproducible. S. 2615; establishes criminal penalties for failing to inform and warn of serious dangers. H.R. 4 (Jobs for America Act); revises Federal law to improve the conditions necessary for economic growth and job creation. General lobbying regarding altering CFPB's operational structure and rulemaking authority. General lobbying on aviation safety. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S. 852 (A Voice for Victims Act); provides that employment-related arbitration agreements shall not be enforceable with respect to any claim related to a tort arising out of rape. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. Lobbying with regard to updating generic drug labeling responsibilities. H.R. 3020/S. 1695 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016); making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2016. Lobbying with regard to mandatory arbitration clauses in nursing home residency contracts.

Work to establish Federal limits on pre-dispute arbitration agreements. Work in opposition to H.R. 526 and S. 357, the Further Asbestos Claims Transparency Act of 2015. Work in support of S.700, the Reducing Exposure to Asbestos Data Base Act of 2015.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 185, Regulatory Accountability Act of 2015; H.R. 1029, EPA Science Advisory Board Reform Act of 2015; H.R. 1030, Secret Science Reform Act of 2015; H.R. 1321, Microbead-Free Waters Act of 2015; S. 543, EPA Science Advisory Board Reform Act of 2015; S. 544, Secret Science Reform Act of 2015; S. 697, Frank R. Lautenberg Chemical Safety for the 21st Century Act; S. 700, READ Act; S. 725, Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act; S. 821, BPA in Food Packaging Right to Know Act; A Bill to Provide for the Implementation of a Sustainable Chemistry Program, and for other Purposes; Bisphenol A; Chemical Safety Board; CPSC Phthalates CHAP; Design for the Environment; Energy Recovery; Flame Retardants; Formaldehyde; FY 2016 Appropriations of Department of Interior; FY 2016 Appropriations Financial Services and General Government (Green Building Policies, Phthalates, CHAP and CPSC); FY 2016 Appropriations of Transportation, Housing and Urban Development, and Related Agencies; Green Building Standards; Hexavalent Chromium; Integrated Risk Information System; Microbeads; Nanotechnology; Permitting Reform; Phthalates; Promoting New Manufacturing Act; Rare Earths; Science Advisory Board; SNUR; Styrene; T-TIP, MTB and Trade Promotion Authority; Toxic Substances Control Act (TSCA)(Including Confidential Business Information)

Client expense: $1,660,000 · Firm income: Not reported

S.1009 - Chemical Safety Improvement Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.696 - Safe Chemicals Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S. 725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R. ___- to reform or modernize the Toxic Substances Control Act; S. 700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and H.R. 562 and S.357 - Furthering Asbestos Claim Transparency Act, all sections.

Client expense: $12,313 · Firm income: Not reported

S.1009 - Chemical Safety Improvement Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.696 - Safe Chemicals Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S.697 - Frank R. Lautenberg Chemical Safety for the 21st Century Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); S. 725 - Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act, all sections (e.g., safety standard, preemption, confidential business information, and prioritization); H.R. ___- to reform or modernize the Toxic Substances Control Act; S. 700 - Reducing Exposure to Asbestos Database Act of 2015, all sections; and H.R. 562 and S.357 - Furthering Asbestos Claim Transparency Act, all sections.

Client expense: $174,660 · Firm income: Not reported

Troop Talent Act S.700/H.R.1796; National Defense Authorization Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Troop Talent Act S.700/H.R.1796; National Defense Authorization Act

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Work to establish Federal limits on pre-dispute arbitration agreements. Work in opposition to H.R. 526 and S.357, The Further Asbestos Claims Transparency Act of 2015. Work in support o f S.700, The Reducing Exposure to Asbestos Data Base Act of 2015.

Client expense: Not reported · Firm income: $50,000

Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)